|
ACN9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.284570E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.554400E-01 |
| Normal-vs-Stage2 |
2.564000E-01 |
| Normal-vs-Stage3 |
8.995500E-02 |
| Normal-vs-Stage4 |
2.611000E-01 |
| Stage1-vs-Stage2 |
4.016200E-01 |
| Stage1-vs-Stage3 |
3.403800E-02 |
| Stage1-vs-Stage4 |
2.519600E-01 |
| Stage2-vs-Stage3 |
3.949900E-02 |
| Stage2-vs-Stage4 |
7.311600E-01 |
| Stage3-vs-Stage4 |
9.320100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.003800E-01 |
| Normal-vs-AfricanAmerican |
2.257800E-01 |
| Normal-vs-Asian |
5.200400E-01 |
| Caucasian-vs-AfricanAmerican |
5.124000E-01 |
| Caucasian-vs-Asian |
6.058200E-01 |
| AfricanAmerican-vs-Asian |
5.649200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.377740E-02 |
| Normal-vs-Female |
1.433980E-01 |
| Male-vs-Female |
4.209400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.938400E-01 |
| Normal-vs-Extreme_Weight |
1.093370E-01 |
| Normal-vs-Obese |
2.798000E-01 |
| Normal-vs-Extreme_Obese |
3.665600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.802160E-01 |
| Normal_Weight-vs-Obese |
3.144800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.274600E-01 |
| Extreme_Weight-vs-Obese |
7.497400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.814000E-01 |
| Obese-vs-Extreme_Obese |
6.637000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.453000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.006560E-01 |
| Normal-vs-Age(61-80Yrs) |
2.989600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.994000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.224400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.521000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.924800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.976400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.184600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.607000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.13519999967293E-07 |
| Normal-VS-Type2 PRCC |
4.657800E-03 |
| Normal-VS-KIRP CIMP |
1.917980E-02 |
| Normal-VS-Unclassified PRCC |
8.528300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.20869980690941E-11 |
| Type1 PRCC-VS-KIRP CIMP |
3.021100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.17690000043392E-07 |
| Type2 PRCC-VS-KIRP CIMP |
8.581000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.222400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.292400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.076800E-01 |
| Normal-vs-N1 |
2.817000E-03 |
| Normal-vs-N2 |
3.506100E-02 |
| N0-vs-N1 |
1.319550E-02 |
| N0-vs-N2 |
3.155200E-01 |
| N1-vs-N2 |
9.144400E-01 |
|
|
